Dr. Ballester is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
903 Providence Pl #443
Providence, RI 02903Phone+1 518-728-1709
Education & Training
University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 1988 - 1988
Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 1977 - 1980- Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 1973 - 1974
Huron HospitalInternship, Transitional Year, 1972 - 1973
Universidad Nacional de CordobaClass of 1971
Certifications & Licensure
LA State Medical License 2007 - Present
IA State Medical License 2013 - 2013
WV State Medical License 2007 - 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer Start of enrollment: 1997 Oct 01
- Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM) Start of enrollment: 2008 Aug 01
- Aplidin - Dexamethasone in Relapsed/Refractory Myeloma Start of enrollment: 2010 Jun 01
Publications & Presentations
PubMed
- 7 citationsCytogenetic Alterations in Multiple Myeloma: Prognostic Significance and the Choice of Frontline TherapyFlavia Stella, Estela Marta Pedrazzini, Mara Agazzoni, Oscar Ballester, Irma Slavutsky
Cancer Investigation. 2015-10-27 - 6 citationsFrontline therapy for multiple myeloma: a concise review of the evidence based on randomized clinical trials.Sobia Yaqub, Gabriela Ballester, Oscar Ballester
Cancer Investigation. 2013-10-01 - 26 citationsInhibition of Nuclear Factor Kappa B activation in Early-Stage Chronic Lymphocytic Leukemia by Omega-3 Fatty AcidsJohannes F. Fahrmann, Oscar Ballester, Gabriela Ballester, Theodore R. Witte, Alexander J. Salazar
Cancer Investigation. 2013-01-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
